Brexit: 'No guarantee' of medicines if no EU deal agreed

14 July 2019 - Scottish Brexit Secretary Mike Russell has said he cannot absolutely guarantee the supply of medicine to ...

Read more →

New treatment approved for patients with breast cancer in Scotland

8 July 2019 - A new drug for patients with advanced breast cancer has been approved for use by the ...

Read more →

SMC - July 2019 decisions

8 July 2019 - A medicine used to treat advanced breast cancer has today been accepted by the Scottish Medicines ...

Read more →

SMC - June 2019 decisions

10 June 2019 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...

Read more →

New cancer drugs approved for NHS use in Scotland

13 May 2019 - The Scottish Medicines Consortium accepted the use of new medicines to treat patients with breast and skin ...

Read more →

SMC - May 2019 decisions

13 May 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...

Read more →

Life-changing drug for chronic migraine approved in Scotland

8 April 2019 - The Scottish Medicines Consortium (SMC) announced that Aimovig (erenumab) has been accepted for adults who have ...

Read more →

SMC - April 2019 decisions

8 April 2019 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...

Read more →

Keeping up the PACE at the Scottish Medicines Consortium

26 March 2019 - There are many ways that patient centricity could be delivered when doing a health technology assessment. ...

Read more →

SMC says ‘no’ to Novartis’ Kymriah for adults with lymphoma

11 March 2019 - Adults with lymphoma will not be able to access Novartis’ CAR-T therapy Kymriah on the NHS ...

Read more →

SMC - March 2019 decisions

11 March 2019 - The Scottish Medicines Consortium has today published advice accepting two new medicines. ...

Read more →

Yescarta rejected among other SMC decisions

12 February 2019 - Gilead's CAR-T therapy Yescarta (axicabtagene ciloleucel) has been rejected by the Scottish Medicines Consortium (SMC) for ...

Read more →

SMC - February 2019 decisions

11 February 2019 - A medicine used to treat a rare blood cancer in children and young adults has today  ...

Read more →

Life-extending drug Perjeta approved for secondary breast cancer

14 January 2019 - A drug used to treat advanced breast cancer has been approved for use on the NHS ...

Read more →

SMC - January 2019 decisions

14 January 2019 - A medicine used to treat advanced breast cancer has today been accepted by the SMC for ...

Read more →